302 related articles for article (PubMed ID: 5990470)
21. [Comparison of medium-range cardiac glycosides].
Assmann I; Fiehring H; Schmidt H; Hesse P; Banse P
Dtsch Gesundheitsw; 1971 Dec; 26(50):2355-7. PubMed ID: 5145434
[No Abstract] [Full Text] [Related]
22. [Therapeutic action of digitalis and substances with analogous action. Lecture 3].
Messini M
Clin Ter; 1971 Feb; 56(3):199-211. PubMed ID: 4325685
[No Abstract] [Full Text] [Related]
23. [Treatment of heart failure in hypertension].
Linss G; Scholze J
Z Arztl Fortbild (Jena); 1985; 79(17):727-32. PubMed ID: 2932861
[No Abstract] [Full Text] [Related]
24. [Study of the activity of a cardioactive glucoside, proscillaridin A, in ambulatory patients].
Parenti B; Cavasonza G
Minerva Cardioangiol; 1971 Jul; 19(7):376-83. PubMed ID: 5106123
[No Abstract] [Full Text] [Related]
25. [On the clinical action of a new derivative of maritime squill (proscillaridinA)].
De Benedetti F; Rizzo F
Minerva Med; 1967 Dec; 58(96):4267-76. PubMed ID: 6083288
[No Abstract] [Full Text] [Related]
26. [Principles and directives for practical treatment with cardiac glycosides].
Dörffel EF
Z Arztl Fortbild (Jena); 1971 Mar; 65(5):237-44. PubMed ID: 4997296
[No Abstract] [Full Text] [Related]
27. [Frequent errors in the therapy of heart disease].
Heinecker R
Wien Med Wochenschr; 1982 Nov; 132(22):531-6. PubMed ID: 6132496
[No Abstract] [Full Text] [Related]
28. Treatment of chronic right-heart lesions. Proscillaridin for cor pulmonale and the senile heart.
Neumann H
Geriatrics; 1966 Jun; 21(6):180-5. PubMed ID: 5949184
[No Abstract] [Full Text] [Related]
29. [The clinical use of a new cardioactive glycoside: proscillaridin A].
Maiorano G; Arbore S
Minerva Med; 1967 Dec; 58(96):4243-6. PubMed ID: 6083285
[No Abstract] [Full Text] [Related]
30. [Action of sparteine on cardiac output: radiocardiographic research].
Modica G; Musco A; Cascone O; Amaro A
Boll Soc Ital Cardiol; 1966; 11(4):1093-9. PubMed ID: 5992022
[No Abstract] [Full Text] [Related]
31. [Data on the hospital treatment of heart disease patients with proscillaridin A].
Saccabusi E
Recenti Prog Med; 1966 Jul; 41(1):XLIII-LIV. PubMed ID: 6014476
[No Abstract] [Full Text] [Related]
32. Drug-pacemaker interactions.
Nevins MA
J Thorac Cardiovasc Surg; 1971 Apr; 61(4):610-6. PubMed ID: 4927088
[No Abstract] [Full Text] [Related]
33. [Indications, contra-indications and dosage of cardiac glycosides controlled by plasma levels in the aged].
Hötter GJ
Z Gerontol; 1987; 20(1):8-12. PubMed ID: 3577317
[TBL] [Abstract][Full Text] [Related]
34. [Action of oral proscillaridin treatment in various forms of heart insufficiency].
Muth HW; Weyer H
Med Welt; 1965 Dec; 51():2883-6. PubMed ID: 5884860
[No Abstract] [Full Text] [Related]
35. The role of glucagon in cardiac therapy.
Parmley WW
N Engl J Med; 1971 Sep; 285(14):801-2. PubMed ID: 5567270
[No Abstract] [Full Text] [Related]
36. [Clinical experimental studies with the heart glycoside, proscillaridin, with special reference to its enteral resorption rate].
Belz GG
Med Klin; 1968 Jan; 63(3):96-102. PubMed ID: 5691836
[No Abstract] [Full Text] [Related]
37. Mechanisms and quantitative assessment of drug effects on cardiac output with a new model of the circulation.
Greenway CV
Pharmacol Rev; 1981 Dec; 33(4):213-51. PubMed ID: 7041140
[No Abstract] [Full Text] [Related]
38. [Experiences with the cardiac glycoside Proscillaridin A (Sandoscill)].
Amirfallah A; Einert HJ
Munch Med Wochenschr; 1967 Aug; 109(33):1690-2. PubMed ID: 5631640
[No Abstract] [Full Text] [Related]
39. [New aspects of glycoside therapy].
Klepzig H
Z Allgemeinmed; 1972 Mar; 48(9):418-21. PubMed ID: 4402437
[No Abstract] [Full Text] [Related]
40. [Clinical observations during accumulative oral glycoside therapy with meproscillarin (author's transl)].
Pozenel H
Arzneimittelforschung; 1978; 28(3a):560-2. PubMed ID: 348205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
